Education
About Us
Working with TipRanks
Follow Us
Colgate-Palmolive (CL)
NYSE:CL
CL Stock Chart & Stats
$78.81
-$0.03(-0.03%)
At close: 4:00 PM EST
$78.81
-$0.03(-0.03%)
Day’s Range― - ―
52-Week Range$74.55 - $100.18
Previous CloseN/A
Volume1.11M
Average Volume (3M)7.16M
Market Cap
$62.91B
Enterprise Value$72.10B
Total Cash (Recent Filing)$1.28B
Total Debt (Recent Filing)$8.42B
Price to Earnings (P/E)21.9
Beta0.11
Next Earnings
Jan 30, 2026EPS Estimate
0.92Last Dividend Ex-Date
Oct 17, 2025Dividend Yield2.64%
Share Statistics
EPS (TTM)0.91
Shares Outstanding806,064,940
10 Day Avg. Volume7,675,992
30 Day Avg. Volume7,160,298
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)350.65
Price to Sales (P/S)3.70
P/FCF Ratio20.96
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue3.59
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda14.99
Forecast
1Y Price Target
$87.75Price Target Upside11.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost EfficienciesThe restructuring program should help yield cost efficiencies in the supply chain to drive earnings growth.
Emerging Markets GrowthThe company benefits from structurally higher growth in emerging markets, which make up 45% of its sales mix, and solid market share gains in key segments.
Pet Business GrowthColgate has a fairly unique and underappreciated high growth pet business that gets too little attention.
Bears Say
Global Category SlowdownManagement emphasized slowdowns around the globe, with North America and Europe experiencing weaker category growth due to inflationary pressures.
Gross Margin PressureGross margins were -100 bps below consensus and -180 bps year-over-year, driven by greater raw material costs and fixed cost deleveraging from lower volumes.
Q3 PerformanceColgate-Palmolive reported a soft Q3 result with muted organic sales growth and missed consensus on both sales and gross margins.
Colgate-Palmolive News
CL FAQ
What was Colgate-Palmolive’s price range in the past 12 months?
Colgate-Palmolive lowest stock price was $74.55 and its highest was $100.18 in the past 12 months.
What is Colgate-Palmolive’s market cap?
Colgate-Palmolive’s market cap is $62.91B.
When is Colgate-Palmolive’s upcoming earnings report date?
Colgate-Palmolive’s upcoming earnings report date is Jan 30, 2026 which is in 73 days.
How were Colgate-Palmolive’s earnings last quarter?
Colgate-Palmolive released its earnings results on Oct 29, 2025. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.889 by $0.021.
Is Colgate-Palmolive overvalued?
According to Wall Street analysts Colgate-Palmolive’s price is currently Undervalued.
Does Colgate-Palmolive pay dividends?
Colgate-Palmolive pays a Quarterly dividend of $0.52 which represents an annual dividend yield of 2.64%. See more information on Colgate-Palmolive dividends here
What is Colgate-Palmolive’s EPS estimate?
Colgate-Palmolive’s EPS estimate is 0.92.
How many shares outstanding does Colgate-Palmolive have?
Colgate-Palmolive has 806,064,940 shares outstanding.
What happened to Colgate-Palmolive’s price movement after its last earnings report?
Colgate-Palmolive reported an EPS of $0.91 in its last earnings report, beating expectations of $0.889. Following the earnings report the stock price went down -1.828%.
Which hedge fund is a major shareholder of Colgate-Palmolive?
Currently, no hedge funds are holding shares in CL
Colgate-Palmolive Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$87.75 (11.34% Upside)
$87.75 (11.34% Upside)
Blogger Sentiment
Bullish
CL Sentiment 93%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 6.7%
Last 30 Days ▲ 6.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.58%
12-Months-Change
Fundamentals
Return on Equity
450.35%
Trailing 12-Months
Asset Growth
4.41%
Trailing 12-Months
Company Description
Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
CL Company Deck
CL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed outlook for Colgate-Palmolive. While the company is committed to its strategic initiatives and sees potential in emerging markets and innovation, challenges in developed markets, formula changes, and pressures in China pose significant headwinds.View all CL earnings summariesCL Net sales Breakdown
77.70% Oral, Personal and Home Care
22.30% Pet Nutrition
CL Stock 12 Month Forecast
Average Price Target
$87.75
▲(11.34% Upside)
Technical Analysis
Ownership Overview
0.14% Insiders
21.21% Mutual Funds
15.02% Other Institutional Investors
40.49% Public Companies and Individual Investors